Bing Lim
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$4.2MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $4.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 5, 2026 | NIH | SBIR Phase II Development of a stem-cell derived thymic cell therapy to treat patients with athymia | $1.0M | THYMMUNE THERAPEUTICS INC |
| Apr 28, 2025 | NIH | SBIR Phase II Development of a stem-cell derived thymic cell therapy to treat patients with athymia | $1.0M | THYMMUNE THERAPEUTICS INC |
| Feb 23, 2024 | NIH | SBIR Phase II Development of a stem-cell derived thymic cell therapy to treat patients with athymia | $1.0M | THYMMUNE THERAPEUTICS INC |
| Mar 21, 2023 | NIH | SBIR Phase II Development of a stem-cell derived thymic cell therapy to treat patients with athymia | $287K | THYMMUNE THERAPEUTICS INC |
| Apr 15, 2022 | NIH | SBIR Phase I Development of a stem-cell derived thymic cell therapy to treat patients with athymia | $587K | THYMMUNE THERAPEUTICS INC |
| Apr 14, 2022 | NIH | SBIR Phase II Development of a stem-cell derived thymic cell therapy to treat patients with athymia | $300K | THYMMUNE THERAPEUTICS INC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#364
Awards as PI#315
Patents#273
Companies
- THYMMUNE THERAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.